Oxboro Medical Announces Planned Acquisition

Definitive Agreement Signed for the Acquisition of Sterion(R);

Expected to Nearly Double Oxboro's Annual Sales



Apr 30, 2001, 01:00 ET from Oxboro Medical, Inc.

    MINNEAPOLIS, April 30 /PRNewswire/ -- Oxboro Medical, Inc. (Nasdaq: OMED),
 a Minneapolis-based developer and marketer of single-use disposable medical
 supplies, today announced that it has entered into a definitive agreement to
 acquire substantially all the assets of Sterion(R), a business unit of Johnson
 & Johnson Medical, a division of Ethicon, Inc.  Specific terms of the cash
 transaction were not disclosed.
     Sterion(R), with production facilities in Jacksonville, Texas,
 manufactures and markets a proprietary line of surgical instrument
 sterilization containers and related disposable supplies which are used by
 hospitals, surgical centers and clinics worldwide.
     J. David Berkley, president of Oxboro Medical, said, "This an important
 step forward for our company.  The purchase of Sterion(R) fulfills one of our
 three stated major avenues for Oxboro's growth, represents an excellent
 strategic fit for Oxboro, and expands our business base in markets that we
 understand well.
     "Because Oxboro already sells its established product lines into the same
 markets that Sterion(R) serves, namely hospital Surgical Departments and
 Central Sterile Reprocessing Departments, we see strong opportunities for
 synergy in our sales and marketing efforts.  The Sterion(R) product line is
 recognized for quality and innovation, has strong intellectual property
 protection, well-established manufacturing processes and is supported by a
 talented and dedicated employee base.  We look forward to capitalizing on the
 significant opportunities that this transaction represents for Oxboro,"
 Berkley said.
     Completion of the transaction, which is subject to the satisfaction of
 certain customary conditions prior to closing, is expected in May.
     Oxboro Medical, Inc., with fiscal year 2000 net sales of $4.6 million, was
 incorporated in Minnesota in 1978.  Oxboro develops, assembles, and markets
 single-use disposable medical supplies and medical and surgical devices.
 Principal medical products produced and sold by Oxboro include silicone
 surgical loops, silicone and fabric surgical clamp covers, surgical instrument
 protection guards, suture aid booties, surgical instrument identification
 sheet and roll tape, surgical instrument cleaning brushes and various holders
 and organizers for surgical instruments used in the operating room.  Oxboro's
 common stock is traded on the Nasdaq SmallCap Market under the symbol OMED.
 More information about Oxboro is available on the company's website at
 http://www.oxboromedical.com
     Except for historical information contained herein, the disclosures in
 this news release are forward-looking statements which could be affected by
 certain risks and uncertainties, and actual results may differ materially,
 depending on a variety of factors.  These risks are described in the Company's
 Annual Report on Form 10-KSB for the year ended Sept. 30, 2000, and Form
 10-QSB for the quarter ended Dec. 31, 2000.
 
     For more information, contact Doug Ewing, 612-344-1036, or Julia Nelson,
 612-344-1017, both of BlueFire Partners, for Oxboro Medical, Inc., or J. David
 Berkley, President of Oxboro Medical, Inc., 763-755-9516.
 
                     MAKE YOUR OPINION COUNT -  Click Here
                http://tbutton.prnewswire.com/prn/11690X33921936
 
 

SOURCE Oxboro Medical, Inc.
    MINNEAPOLIS, April 30 /PRNewswire/ -- Oxboro Medical, Inc. (Nasdaq: OMED),
 a Minneapolis-based developer and marketer of single-use disposable medical
 supplies, today announced that it has entered into a definitive agreement to
 acquire substantially all the assets of Sterion(R), a business unit of Johnson
 & Johnson Medical, a division of Ethicon, Inc.  Specific terms of the cash
 transaction were not disclosed.
     Sterion(R), with production facilities in Jacksonville, Texas,
 manufactures and markets a proprietary line of surgical instrument
 sterilization containers and related disposable supplies which are used by
 hospitals, surgical centers and clinics worldwide.
     J. David Berkley, president of Oxboro Medical, said, "This an important
 step forward for our company.  The purchase of Sterion(R) fulfills one of our
 three stated major avenues for Oxboro's growth, represents an excellent
 strategic fit for Oxboro, and expands our business base in markets that we
 understand well.
     "Because Oxboro already sells its established product lines into the same
 markets that Sterion(R) serves, namely hospital Surgical Departments and
 Central Sterile Reprocessing Departments, we see strong opportunities for
 synergy in our sales and marketing efforts.  The Sterion(R) product line is
 recognized for quality and innovation, has strong intellectual property
 protection, well-established manufacturing processes and is supported by a
 talented and dedicated employee base.  We look forward to capitalizing on the
 significant opportunities that this transaction represents for Oxboro,"
 Berkley said.
     Completion of the transaction, which is subject to the satisfaction of
 certain customary conditions prior to closing, is expected in May.
     Oxboro Medical, Inc., with fiscal year 2000 net sales of $4.6 million, was
 incorporated in Minnesota in 1978.  Oxboro develops, assembles, and markets
 single-use disposable medical supplies and medical and surgical devices.
 Principal medical products produced and sold by Oxboro include silicone
 surgical loops, silicone and fabric surgical clamp covers, surgical instrument
 protection guards, suture aid booties, surgical instrument identification
 sheet and roll tape, surgical instrument cleaning brushes and various holders
 and organizers for surgical instruments used in the operating room.  Oxboro's
 common stock is traded on the Nasdaq SmallCap Market under the symbol OMED.
 More information about Oxboro is available on the company's website at
 http://www.oxboromedical.com
     Except for historical information contained herein, the disclosures in
 this news release are forward-looking statements which could be affected by
 certain risks and uncertainties, and actual results may differ materially,
 depending on a variety of factors.  These risks are described in the Company's
 Annual Report on Form 10-KSB for the year ended Sept. 30, 2000, and Form
 10-QSB for the quarter ended Dec. 31, 2000.
 
     For more information, contact Doug Ewing, 612-344-1036, or Julia Nelson,
 612-344-1017, both of BlueFire Partners, for Oxboro Medical, Inc., or J. David
 Berkley, President of Oxboro Medical, Inc., 763-755-9516.
 
                     MAKE YOUR OPINION COUNT -  Click Here
                http://tbutton.prnewswire.com/prn/11690X33921936
 
 SOURCE  Oxboro Medical, Inc.